Showing results (91-100 of 327) with videos related to
Sort By:
Pageof 33
CNS Drugs|December 3, 2011
Pharmacological management of acute and persistent aggression in forensic psychiatry settingsLeslie Citrome, Jan VolavkaDialogues in Clinical Neuroscience|October 29, 2011
Optimizing dosing in atypical neuroleptic monotherapyFabien Trémeau, Leslie CitromeExpert Opinion on Investigational Drugs|February 8, 2020
The treatment of acute agitation associated with schizophrenia or bipolar disorder: investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapyKristen Ward, Leslie CitromeHarvard Review of Psychiatry|January 8, 2021
Specific Anti-hostility Effects of Atypical Antipsychotics in Persons with Schizophrenia: From Clozapine to CariprazineLeslie Citrome, Jan VolavkaExpert Opinion on Drug Safety|March 11, 2024
Tolerability and safety outcomes of first-line oral second-generation antipsychotics in patients with schizophreniaKristen Ward, Leslie CitromeBjpsych Bulletin|January 13, 2016
Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depressionAntony Loebel, Leslie CitromeSchizophrenia Bulletin|May 13, 2011
Pathways to aggression in schizophrenia affect results of treatmentJan Volavka, Leslie CitromeCore Evidence|January 12, 2011
Paliperidone: the evidence of its therapeutic value in schizophreniaJoshua Kantrowitz, Leslie CitromePostgraduate Medicine|October 30, 2004
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioningLeslie Citrome, Jan VolavkaJournal of Psychopharmacology (Oxford, England)|November 11, 2005
Do guidelines for severe mental illness promote physical health and well-being?Leslie Citrome, David YeomansPageof 33